All News and Events

02.10.25 Web Release

Innospera Pharma receives the “Investment of the Year” Award at Anges Québec 2025 Annual Meeting

09.06.25 Press Release

Innospera Pharma Appoints Dr. Glenn Crater as Chief Medical Officer to Support Advancement of ING-006 Toward the Clinic

12.05.25 Press Release

Innospera Pharma to Present Key Comparative Data About Novel GPCR Modulator for IPF at ATS 2025 Annual Meeting

05.05.25 Press Release

François Ravenelle, PhD appointed President and CEO of Innospera Pharma to lead next phase of growth

01.05.25 Investissement Québec Press Release

Gouvernement du Québec, Seido Capital and Anges Québec combine to provide Innospera with $5M seed financing